Manganese Enhances the Osteogenic Effect of Silicon‐Hydroxyapatite Nanowires by Targeting T Lymphocyte Polarization
Advanced Science · 2024
DOI: 10.1002/advs.202305890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Ruomei Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, 500 Qu…. Hauptthemen laut MEDLINE: Osteogenesis, Nanowires. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Clinical Research Plan of SHDC, Innovative Research Team of High-level Local Universities in Shanghai.
Abstract (Originalsprache)
Biomaterials encounter considerable challenges in extensive bone defect regeneration. The amelioration of outcomes may be attainable through the orchestrated modulation of both innate and adaptive immunity. Silicon‐hydroxyapatite, for instance, which solely focuses on regulating innate immunity, is inadequate for long‐term bone regeneration. Herein, extra manganese (Mn)‐doping is utilized for enhancing the osteogenic ability by mediating adaptive immunity. Intriguingly, Mn‐doping engenders heightened recruitment of CD4 + T cells to the bone defect site, concurrently manifesting escalated T helper (Th) 2 polarization and an abatement in Th1 cell polarization. This consequential immune milieu yields a collaborative elevation of interleukin 4, secreted by Th2 cells, coupled with attenuated interferon gamma, secreted by Th1 cells. This orchestrated interplay distinctly fosters the osteogenesis of bone marrow stromal cells and effectuates consequential regeneration of the mandibular bone defect. The modulatory mechanism of Th1/Th2 balance lies primarily in the indispensable role of manganese superoxide dismutase (MnSOD) and the phosphorylation of adenosine 5′‐monophosphate‐activated protein kinase (AMPK). In conclusion, this study highlights the transformative potential of Mn‐doping in amplifying the osteogenic efficacy of silicon‐hydroxyapatite nanowires by regulating T cell‐mediated adaptive immunity via the MnSOD/AMPK pathway, thereby creating an anti‐inflammatory milieu favorable for bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, 500 Quxi Road, Shanghai, 200011, China.
- Department of Stomatology, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, 1665 Kongjiang Road, Shanghai, 200092, China.
ORCID-Profile: Ruomei Li, Lunguo Xia, Bing Fang
Förderung
- National Natural Science Foundation of China
- Clinical Research Plan of SHDC
- Innovative Research Team of High-level Local Universities in Shanghai
- Key Laboratory of Translational Medicine on Ear and Nose disease
Zitieren
APA
Li, R., Zhu, Z., Zhang, B., Jiang, T., Zhu, C., Mei, P., Jin, Y., Wang, R., Li, Y., Guo, W., Liu, C., Xia, L., & Fang, B. (2024). Manganese Enhances the Osteogenic Effect of Silicon‐Hydroxyapatite Nanowires by Targeting T Lymphocyte Polarization. Advanced Science. https://doi.org/10.1002/advs.202305890
Vancouver
Li R, Zhu Z, Zhang B, Jiang T, Zhu C, Mei P, et al. Manganese Enhances the Osteogenic Effect of Silicon‐Hydroxyapatite Nanowires by Targeting T Lymphocyte Polarization. Advanced Science. 2024. doi:10.1002/advs.202305890
BibTeX
@article{Li2024,
author = {Li, Ruomei and Zhu, Zhiyu and Zhang, Bolin and Jiang, Ting and Zhu, Cheng and Mei, Peng and Jin, Yu and Wang, Ruiqing and Li, Yixin and Guo, Weiming and Liu, Chengxiao and Xia, Lunguo and Fang, Bing},
title = {Manganese Enhances the Osteogenic Effect of Silicon‐Hydroxyapatite Nanowires by Targeting T Lymphocyte Polarization},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202305890}
}
EUVIMED